LAPTM5 and nonpapillary renal cell carcinoma: We found that the number of cell clones and the cell proliferation rate (Figures 2(b) and 2(c)) in the LAPTM5-overexpression group were higher than that in controls, indicating that LAPTM5 promoted cell proliferation in ccRCC.